1. Lorlatinib for the Treatment of Inflammatory Myofibroblastic Tumor after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
    Toshinari Yagi et al, 2024, Internal Medicine CrossRef
  2. Epithelioid inflammatory myofibroblastic sarcoma treated with Alectinib: a case report and literature review
    Xinchun Wu et al, 2024, Frontiers in Oncology CrossRef
  3. Crizotinib in Sarcomatous Malignancies Harboring ALK Fusion With a Definitive Partner(s): Response and Efficacy
    Jinchun Wu et al, 2021, Frontiers in Oncology CrossRef
  4. Crizotinib
    , 2019, Reactions Weekly CrossRef
  5. Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review
    Weidong Dou et al, 2023, Frontiers in Oncology CrossRef
  6. Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature
    Shefali Chopra et al, 2022, Brain Tumor Pathology CrossRef
  7. Case Report: Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion
    XiaoQing Li et al, 2023, Frontiers in Oncology CrossRef
  8. Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib
    Mengmeng Li et al, 2023, Frontiers in Oncology CrossRef
  9. Rare giant epithelioid inflammatory myofibroblastic sarcoma of the abdominal cavity in a child: a case report and review of the literature
    Jinzhou Li et al, 2024, Frontiers in Oncology CrossRef
  10. Inflammatory myofibroblastic tumor in the liver: a case report
    Yinying Meng et al, 2024, Frontiers in Oncology CrossRef